Acelrx Pharmaceuticals reported $147K in Ordinary Share Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Acelrx Pharmaceuticals ACRX:US $ 0.15M 0.01M
Acura Pharmaceuticals ACUR:US 651K 430K
Baxter International BAX:US $ 683M 0M
Becton, Dickinson and BDX:US $ 365M 0M
Cara Therapeutics CARA:US $ 53K 0
Heron Therapeutics HRTX:US $ 1.02M 0M
Intra Cellular Therapies ITCI:US $ 0.01M 0M
Johnson & Johnson JNJ:US $ 3120M 0M
Pain Therapeutics PTIE:US $ 0.04M 0M
Smiths SMIN:LN 146M 3M
Teva Pharmaceutical TEVA:IT 57M 0
Xeris Pharmaceuticals Inc XERS:US $ 14K 1000